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Intraoperative application of stromal vascular fraction (SVF) of adipose tissue, 
requires a fast and efficient isolation procedure of adipose tissue. This review was 
performed to systematically assess and compare procedures currently used for the 
intraoperative isolation of cellular SVF (cSVF) and tissue SVF (tSVF) which still 
contains the extracellular matrix. 
Methods 
Pubmed, EMBASE and The Cochrane Central Register of controlled trials databases 
were searched for studies that compare procedures for intraoperative isolation of 
SVF (searched 28th of September, 2016). Outcomes of interest were cell yield, 
viability of cells, composition of SVF, duration, cost and procedure characteristics. 
Procedures were subdivided in procedures resulting in a cSVF or tSVF.   
Results 
Thirteen out of 3038 studies were included, evaluating eighteen intraoperative 
isolation procedures, were considered eligible. In general, cSVF and tSVF 
intraoperative isolation procedures had comparable cell yield, cell viability and SVF 
composition compared to a non-intraoperative (i.e. culture lab-based collagenase 
protocol) control group within the same studies. The majority of intraoperative 
isolation procedures are less time consuming than non-intraoperative control groups, 
however.  
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Conclusion 
Intraoperative isolation procedures are less time-consuming than non-intraoperative 
control group with similar cell yield, viability of cells and composition of SVF and 
therefore more suitable for use in the clinic. Nevertheless, none of the intraoperative 
isolation procedures could be designated as preferred procedure to isolate SVF. 
 
 
Keywords: Lipografting, Stromal vascular fraction, Adipose derived stem/stromal 
cells, Non-enzymatic isolation, Enzymatic isolation, Collagenase 
1. Introduction 
Adipose tissue seems to be an outstanding source for regenerative therapies, since 
it is an easy accessible source for adipose-derived stem or stromal cells (ASCs). 
Adipose tissue can easily be harvested with liposuction, a low risk procedure that 
can be performed under local anesthesia. Several clinical trials have been published 
using ASCs for soft tissue reconstruction (Tanikawa et al. 2013), cardiac repair 
(Perin et al. 2014), pulmonary repair (Tzouvelekis et al. 2013) and cartilage repair 
(Jo et al. 2014). All these trials show promising results for future use of ASCs in 
tissue repair and regeneration.  
To harvest ASCs, adipose tissue or lipoaspirate is subjected to enzymatic 
dissociation followed by several centrifugation steps (Bourin et al. 2013), which is a 
relative long-lasting procedure that cannot be performed during surgery. The cell 
population obtained by this enzymatic digestion and centrifugation is the stromal 
vascular fraction (SVF), containing ASCs, endothelial cells, supra-adventitial cells, 
lymphocytes and pericytes (Eto et al. 2009, Bourin et al. 2013). ASCs in vivo are 
characterized as CD31min/CD45min/CD34pos/CD90pos/CD105low cells 
(Yoshimura et al. 2006). After isolation, the SVF can either be used directly in clinical 
procedures or can be cultured to increase the number of cells before using them in 
the clinic (Gir et al. , Suga et al. 2007). In case of cell culturing, only ASCs and their 
precursor cells (supra-adventitial cells and pericytes) are able to adhere and survive 
(Zuk et al. 2001, Zimmerlin et al. 2010). Upon passaging in vitro, the phenotype of 
ASCs starts to deviate from their in vivo phenotype (Spiekman et al., 2016): in this 
process CD34 surface expression is lost, while CD105 expression is up-regulated to 
mention a few (Yoshimura et al. 2006, Corselli et al. 2012). Alternatively, 
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administration of the enzymatically prepared vascular stromal fraction of adipose 
tissue might have a therapeutic capacity that is similar to cultured ASCs. Although, 
no formal scientific evidence exists, the consensus is, that the therapeutic benefit of 
SVF predominantly relies on the abundantly present ASCs. 
 
The current protocol to isolate and culture ASCs from adipose tissue involves 
enzymatic digestion with collagenase. This is a laborious and time consuming 
protocol and requires a specialized culture lab (Good Manufacturing Practice 
facilities (cGMP)), which is not available in most peripheral hospitals (Gimble et al. 
2010). Therefore, intraoperative procedures for SVF isolation are warranted, in 
particular systems that do not employ enzymatic treatment, such as mechanical 
dissociation.  
At present, several (commercial) procedures are available for intraoperative 
isolation of SVF (Aronowitz et al. 2015, Oberbauer et al. 2015). These intraoperative 
isolation procedures differ in various aspects: isolation of a single cell SVF (cellular 
SVF (cSVF)) resulting in a pellet with hardly any volume or isolation of SVF cells 
containing intact cell-cell communications (tissue SVF (tSVF). Most of the enzymatic 
intraoperative isolation procedures result in a cSVF, because of the loss of cell-cell 
communications and extracellular matrix. In most of the non-enzymatic intraoperative 
isolation procedures the cell-cell communications remain intact, resulting in an end 
product with more volume (tSVF). Different studies assessed the cell yield and 
phenotype of the isolated cSVF or tSVF of the various intraoperative isolation 
procedures compared to other intraoperative (commercial) procedures or to the gold 
standard for SVF isolation (non-intraoperative culture lab-based collagenase 
protocols which require cGMP facilities for clinical use, referred to as ‘non-
intraoperative isolation protocol’). Recently, new intraoperative isolation procedures 
are introduced and tested. It is not clear yet if intraoperative isolation procedures 
generate a similar quality and quantity of SVF as non-intraoperative isolation 
protocols. Next to this, the distinction between end products of intraoperative 
isolation procedures, e.g. cSVF and tSVF have never been studied. Therefore, a 
systematic review was performed to assess the efficacy of intraoperative isolation 
procedures of human SVF based on number of cells, cell viability and composition of 
SVF. In addition, duration and costs of the intraoperative isolation procedures were 
compared.    
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2. Material & Methods 
2.1. Protocol and registration 
This study was performed using the PRISMA protocol (Moher et al. 2009). The 
search strategy for this systematic review was based on a Population, Intervention, 
Comparison, and Outcome (PICO) framework (Schardt et al. 2007). The study was 
not registered. 
2.2. Eligibility criteria 
Studies were included when at least two different types of intraoperative isolation 
procedures or one intraoperative isolation procedure with a non-intraoperative 
isolation protocol were assessed using human adipose tissue to isolate SVF. Studies 
need to use the adipose fraction of lipoaspirate. Studies only evaluating 
centrifugation forces, sonication or red blood cell (RBC) lysis buffer were excluded. 
Studies focusing on processing methods of adipose tissue for the use in fat grafting 
were excluded as well as case reports, case series and reviews. Searches were not 
limited to date, language or publication status (Table 1). 
 
2.3. Information sources and search 
Pubmed, EMBASE (OvidSP) and The Cochrane Central Register of controlled trials 
databases were searched (searched 28th September, 2016). The search was 
restricted to human studies. The search terms (Table 2) were based on three 
components: (P) adipose stromal cell, adipose stem cell, stromal vascular fraction, 
autologous progenitor cell, or regenerative cell in combination with (I) cell separation, 
isolation, dissociation, digestion, emulsification, isolation system, cell concentrator 
and finally connected with (C) enzymatic, non-enzymatic, or mechanical.  
2.4. Study selection and data collection process 
Two authors (JAD, AJT) selected studies independently based on the eligibility 
criteria. Inconsistencies were discussed during a consensus meeting. In case of 
disagreement, the senior author (MCH) gave a binding verdict.  
  
 This article is protected by copyright. All rights reserved. 
2.5. Data items  
Search term was partly based on a Population, Intervention, Comparison, Outcome 
(PICO) framework. Outcomes of interest were not included in the search term. For 
this review the outcomes of interest were cell yield, viability of the nucleated cells, 
composition of the SVF and duration, cost and characteristics of the intraoperative 
isolation procedures. Effect sizes were calculated on cell yield and viability in studies 
with a comparison of intraoperative isolation procedures versus regular non-
intraoperative isolation protocols. Differences in harvesting procedure were not taken 
into account.  
2.6. Risk of bias in individual studies 
It is known that the quality of ASCs depends on age and harvest location of the 
donor (Engels et al. 2013, Dos-Anjos Vilaboa et al. 2014, Di Taranto et al. 2015, 
Maredziak et al. 2016). The inclusion of young healthy patients may positively affect 
the results. Therefore, detailed information about demographics are described in this 
review.  
2.7. Summary measurements 
Effect sizes were calculated of the outcome variables cell yield and percentage of 
viable nucleated cells from cSVF between enzymatic intraoperative isolation 
procedures and non-intraoperative isolation protocols (gold standard). The following 
effect size formula was used: effect size = (difference in mean outcomes between 
enzymatic intraoperative isolation procedures and gold standard) / (standard 
deviation of the gold standard). Studies which presented results in mean and 
standard deviation were analyzed. Intraoperative isolation procedures focusing on 
tSVF instead of cSVF were not taken into account in the effect size of cell yield, 
because of different start volumes of lipoaspirate and end volumes of tSVF. 
2.8. Synthesis of results   
In some studies, derivate numbers of graphs are used when the actual number of 
outcomes was not given. Cell types within the SVF can be distinguished based on 
CD marker expression or immuno-staining. To compare SVF compositions between 
different studies and to compare intraoperative procedures with their control (i.e. 
non-intraoperative protocols or other intraoperative procedures) in the same study, 
only CD marker expression was used. Studies evaluating a single CD marker 
expression to analyze different cell types were seen as insufficient distinctive and 
were excluded. Cells were divided into two major groups: CD45min (adipose tissue-
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derived) and CD45pos (blood derived) cells to analyze the expression of stromal 
cells, pericytes, vascular endothelial cells/endothelial progenitor cells, endothelial 
cells, lymphocytes, leukocytes and hematopoietic stem cells. All other cells are 
placed in the category: other cell types. The CD34pos/CD146pos population is 
excluded from analysis because of the inability to discriminate between progenitor 
pericytes and progenitor endothelial cells (Bianchi et al. 2013).  
2.9. Risk of bias across studies 
Included studies could present different outcome variables related to SVF analysis. 
There is a risk that studies did not present a full SVF characterization and thereby 
bias their results. In order to provide an overview of the used outcome variables per 
study, a Modified IFATS/ISCT Index Score was used (see 2.10). The risk of 
publication bias of positive results might be expected in those articles were the 
authors have benefits in the investigated products. Disclosure agreements were 
reviewed for each study. 
2.10. Modified IFATS/ISCT Index Score for the measurement of adipose tissue-
derived stromal vascular fraction 
Studies were assessed based on the reported outcome variables. The assessment 
of quality was evaluated based on the position statement of the International 
Federation of Adipose Therapeutics and Science (IFATS) and the International 
Society of Cellular Therapy (ISCT) (Bourin et al. 2013). The IFATS and ISCTS 
proposed guidelines to develop reproducible standardized endpoints and methods to 
characterize ASCs and SVF cells. For each of the following characterization 
methods a grade was given by the authors (JAD, AJT) to an article if the 
characterization was carried out: viability of nucleated cells, flow cytometry of SVF 
cells, flow cytometry of ASCs (CD13, CD29, CD31, CD34, CD44, CD45, CD73, 
CD90, CD105, CD235a), proliferation and frequency (CFU-F) and functional assays 
(adipogenic, osteogenic and chondrogenic differentiation assays) of ASCs. The 
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3. Results 
3.1. Included studies 
A total of 3038 studies were identified after database searching. 2955 articles were 
excluded after abstract screening. 59 full text studies were assessed on eligibility 
criteria. Fourteen studies were excluded based on the use of a non-intraoperative 
protocol for isolation as experimental method (Yoshimura et al. 2006, Jiang et al. 
2007, Pilgaard et al. 2008, Vykoukal et al. 2008, Al Battah et al. 2011, Fink et al. 
2011, Condé-Green and Lamblet 2012, Okura et al. 2012, Carvalho et al. 2013, 
Escobedo-Lucea et al. 2013, Siciliano et al. 2013, Chen et al. 2014, Doi et al. 2014, 
Seaman et al. 2015). Seven studies described isolation protocols in general but gave 
no results (Hicok and Hedrick , Bernacki et al. 2008, Dubois et al. 2008, Yu et al. 
2011, Zachar et al. 2011, Buehrer and Cheatham 2013, Zhu et al. 2013). Seven 
studies were excluded based on the lack of a control group (i.e. non-intraoperative 
isolation protocols or other intraoperative isolation procedures) (Zuk et al. 2001, 
Zeng et al. 2013, Dos-Anjos Vilaboa et al. 2014, Inoue et al. 2014, Sadighi et al. 
2014, Van Pham et al. 2014, Raposio et al. 2016). Four studies were excluded 
based on their study design (Kim 2014, Marincola 2014, Aronowitz and Hakakian 
2015, Bertheuil and Chaput 2015). Three studies were excluded based on the use of 
culture methods to isolate ASCs, because culture methods are incompatible with 
intraoperative applications (Wu et al. 2012, Busser et al. 2014, Priya et al. 2014). 
Four studies used only centrifugation, centrifugation or RBC lysis buffer as isolation 
protocol and were thereby excluded (Baptista et al. 2009, Markarian et al. 2014, 
Raposio et al. 2014, Amirkhani et al. 2016). Three studies used the blood saline 
fraction of lipoaspirate and were thereby excluded (Francis et al. 2010, Shah et al. 
2013, Cicione et al. 2016). Four studies did not describe an outcome of interest 
(Reshak et al. 2013, Fraser et al. 2014, Yi et al. 2014, Aronowitz et al. 2015). Four 
additional studies were identified through other sources (Fig. 1). Thus, thirteen 
studies with eighteen intraoperative isolation procedures remained for analysis.  
3.2. Study characteristics  
In total, 93 subjects were enrolled in the thirteen studies. Nine studies reported 
gender of which 95% was female (n=58). Nine studies reported the mean age or age 
variance of the subjects and ten other studies described the use of infiltration (Table 
1, supplemental content). No meta-analysis could be performed because the metrics 
and outcomes were too diverse.  
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3. 3. Characteristics of the intraoperative isolation procedures 
All intraoperative isolation procedures are divided into two categories: enzymatic and 
non-enzymatic procedures resulting in cSVF and tSVF respectively (Table 3A and 
table 3B). Eight of the eighteen intraoperative isolation procedures were based on 
enzymatic digestion and ten isolation procedures were based on non-enzymatic 
procedures. Two non-enzymatic procedures, the Residual tissue of emulsified fat 
procedure and the Fractionation of adipose tissue procedure, are named differently, 
but are almost identical. One intraoperative isolation procedure, the Filtrated fluid of 
emulsified fat, is a combined procedure of two other intraoperative isolation 
procedures i.e. the Fractionation of adipose tissue procedure and the Nanofat 
procedure (Tonnard et al. 2013, Mashiko et al. 2016, van Dongen et al. 2016).  
3.3.1 Start volume versus end product 
The Automated isolation system, GID SVF2, Lipokit system and Multi station are 
enzymatic intraoperative isolation procedure that resulted in large average amounts 
of SVF (7.2 ml – 20 ml), suggesting inefficient enzymatic digestions (SundarRaj et al. 
2015, Aronowitz et al. 2016). The non-enzymatic intraoperative isolation procedures 
resulted in larger end volumes than only a pellet. Prior the Lipogems procedure, 130 
ml of adipose tissue can be obtained to mechanical dissociate to 100 ml of 
lipoaspirate. Hence, this a reduction of the volume of 1.3 times, suggesting an 
inefficient mechanical dissociation to our opinion (Bianchi et al. 2013). In contrast, 
the Fractionation of adipose tissue procedure resulted in a 10.4-fold volume 
reduction (van Dongen et al. 2016). For all other intraoperative isolation procedures, 
no data is mentioned about the end volume of the lipoaspirate (Table 3A and table 
3B). 
3.3.2 Duration and costs 
Duration of the intraoperative isolation procedures varied from 5 seconds to 133 
minutes (n=12). Isolation with the Automated isolation system was the longest 
intraoperative isolation procedure (SundarRaj et al. 2015). Shuffling lipoaspirate 5 or 
30 times through a luer-to-luer lock syringe will take 5 or 30 seconds respectively 
and were therefore the fastest procedures (Osinga et al. 2015). In general, the tested 
non-enzymatic procedures take less time than the enzymatic procedures (Table 3A 
and table 3B). 
 
 This article is protected by copyright. All rights reserved. 
The costs of only enzymatic procedures Celution system (2013: $1950 and 
2016: $2400), CHA-station ($710), Multi station (2013: $460 and 2016: $250), Lipokit 
system (2013: $530 and 2016: $450) and GID SVF2 ($1000) are mentioned, the 
enzymatic Celution system being the most expensive (Aronowitz and Ellenhorn 
2013, Aronowitz et al. 2016). No data of non-enzymatic intraoperative procedures 
were available (Table 3A and table 3B). 
 
3.4. Cell yield  
Thirteen studies evaluated the cell yield of eighteen different intraoperative isolation 
procedures (Millan , Lin et al. 2008, Guven et al. 2012, Aronowitz and Ellenhorn 
2013, Bianchi et al. 2013, Doi et al. 2013, Tonnard et al. 2013, Domenis et al. 2015, 
Osinga et al. 2015, SundarRaj et al. 2015, Aronowitz et al. 2016, Mashiko et al. 
2016, van Dongen et al. 2016) (Table 2A and table 2B, supplemental content). The 
reported cell yield after those different procedures varied between 0.19 – 11.7 x 105 
cells per ml in enzymatic intraoperative isolation procedures and between 1.8 – 22.6 
x 105 cells per ml in non-enzymatic intraoperative isolation procedures. Non-
enzymatic intraoperative procedures yielded higher number of cells since the cell 
yield was based on 1ml of end volume, whereas the enzymatic intraoperative 
isolation cell yield was based on the obtained pellet per 1 ml start volume of 
lipoaspirate. Of the enzymatic intraoperative isolation procedures, the Celution 
system, Multi station and Lipokit system were evaluated by more than one group of 
authors (Lin et al. 2008, Aronowitz and Ellenhorn 2013, Domenis et al. 2015, 
Aronowitz et al. 2016). Interestingly, obvious different yields were seen using the 
same procedure in different studies (Lin et al. 2008, Aronowitz and Ellenhorn 2013, 
Domenis et al. 2015, Aronowitz et al. 2016). Reproducibility is thereby questioned in 
our opinion. The cell yield using the enzymatic Celution system was significantly 
higher as compared to the Lipokit system (p=0.004), the Multi station (p=0.049) and 
CHA-station (p<0.001) (Aronowitz and Ellenhorn 2013). In contrast, Domenis et al. 
did not find a statistical difference between the enzymatic Celution system and 
Lipokit system. Moreover, Aronowitz et al. again compared the enzymatic Celution 
system with the Lipokit system and Multi station. This time, Multi station and the 
Lipokit system resulted in significant more cells as compared to the Celution system 
(p<0.05) (Aronowitz et al. 2016). 
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In the non-enzymatic intraoperative isolation procedures, the Squeezed fat, 
Residual fluid of emulsified fat and Fractionation of fat procedures resulted in the 
relative highest cell yields per ml harvested lipoaspirate (Mashiko et al. 2016, van 
Dongen et al. 2016). Non-enzymatic intraoperative isolation procedures such as 
shuffling (5 times and 30 times), the Nanofat procedure and Fastem did not mention 
the begin and end volumes, so the relative yield by isolation cannot be calculated 
(Tonnard et al. 2013, Domenis et al. 2015, Osinga et al. 2015). Osinga et al, 
reported that most of the adipocytes remain intact after shuffling 5 or even 30 times 
(Osinga et al. 2015). Consequently, to our opinion, the effect of shuffling only cannot 
be stated as an isolation procedure. We deem it possible that the lipoaspirate after 
both two procedures did not differ from the initial lipoaspirate obtained at the start of 
the procedure. However, the benefit might be at a different level, because shuffling 
does improve the injectability of lipoaspirates as shown by Tonnard et al. (Tonnard et 
al. 2013). 
More interesting than comparing intraoperative isolation procedures evaluated 
in different studies might be the comparison between an intraoperative isolation 
procedure and a non-intraoperative isolation protocol (gold standard) starting from 
the same lipoaspirate. Six studies reported the results of such comparisons (Table 
4A) (Millan , Lin et al. 2008, Guven et al. 2012, Doi et al. 2013, Domenis et al. 2015, 
SundarRaj et al. 2015). The Automated isolation system and Tissue genesis cell 
isolation system resulted in the same cell yield as the non-intraoperative isolation 
protocol control (effect size, respectively, 0.07 and 0.00) (Doi et al. 2013, SundarRaj 
et al. 2015). Sepax isolated a higher cell yield compared to a non-intraoperative 
isolation protocol (effect size 1.11) (Table 4A) (Guven et al. 2012). Lower cell yield 
was seen after using the Lipokit system compared to the non-intraoperative isolation 
protocol control (effect size -0.52) (Domenis et al. 2015). Interestingly, the highest 
positive as well as the most negative effect sizes were seen with the enzymatic 
Celution system related to regular isolation with a non-intraoperative isolation 
protocol (Lin et al. 2008, Domenis et al. 2015).  
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3.5. Viability of nucleated cells  
Eight studies described viabilities from 39% to 98% of nucleated cells in the SVF. No 
big differences in viability were seen between enzymatic and non-enzymatic 
intraoperative isolation procedures. The Filtrated fluid of emulsified fat procedure 
showed the lowest viability (Mashiko et al. 2016), while the Automated isolation 
system showed the highest viability of nucleated cells of 98% after isolation (Table 
2A and table 2B, supplemental content) (SundarRaj et al. 2015). Three enzymatic 
and three non-enzymatic intraoperative isolation procedures were compared to a 
non-intraoperative isolation protocol regarding the viability of nucleated cells (Table 
4B) (Lin et al. 2008, Doi et al. 2013, SundarRaj et al. 2015). The viability of five 
intraoperative isolation procedures was comparable to their non-intraoperative 
isolation protocol controls; the effect sizes were close to zero in many studies (Table 
4B). Only the Filtrated fluid of emulsified fat procedure showed an effect size of -45.4 
(Mashiko et al. 2016). In general, viability did not differ between non-intraoperative 
isolation protocols and the individual intraoperative isolation procedures tested.  
3.6. Composition of stromal vascular fractions  
The SVF compositions is reported in nine studies evaluating six enzymatic 
procedures and three non-enzymatic procedures. The stromal cell population is 
larger in the SVF isolated by the enzymatic Celution system, Sepax and Tissue 
genesis cell isolation system and the non-enzymatic Residual of emulsified fat and 
Squeezed fat procedures compared to other intraoperative isolation procedures 
(Guven et al. 2012, Aronowitz and Ellenhorn 2013, Doi et al. 2013, Mashiko et al. 
2016) (Table 5, supplemental content). The percentage of stromal cell population of 
the SVF isolated by the enzymatic Celution system only differs with 25.2% between 
two studies (Aronowitz and Ellenhorn 2013, Domenis et al. 2015) and 32.8% 
between two other studies, both evaluated by Aronowitz et al. (Aronowitz and 
Ellenhorn 2013, Aronowitz et al. 2016). In general, non-enzymatic procedures 
yielded same amounts of CD31min/CD34pos stromal cells. 
The stromal cell population, including pericytes, ASCs and supra-adventitial 
cells, are the most important cell types in regenerative therapies because of their 
paracrine effect and multi-lineage differentiation capacity (Zuk et al. 2001, Pawitan 
2014). 
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Pericytes defined using other CD markers than to define the stromal cell population 
are placed separately in the table. The enzymatic Celution system evaluated by Lin 
et al. resulted in the lowest percentage of pericytes in the SVF (0.8%), but used 
more than three CD markers to detect pericytes (Lin et al. 2008). SundarRaj et al. 
resulted in a higher percentage (2.0%) of pericytes in SVF obtained by the 
Automated isolation system, but used only two CD markers to determine the pericyte 
population and other cell types (SundarRaj et al. 2015). The use of multiple CD 
markers results in a more specific population than the use of less CD markers and 
so a lower percentage of that specific cell type e.g. pericytes (Bianchi et al. 2013). 
Bianchi et al. used CD34min/CD146pos/CD90pos to detect the pericyte-like 
population in the SVF and isolated the highest percentage of pericytes using the 
non-enzymatic Lipogems procedure as compared to other intraoperative isolation 
procedures (Bianchi et al. 2013). However, Bianchi et al. mostly used other 
combinations of CD markers in comparison to other studies (Bianchi et al. 2013). 
This renders their SVF composition incomparable with SVF compositions obtained 
by other intraoperative isolation procedures.  
 The enzymatic procedures: Automated isolation system, Tissue genesis cell 
isolation system and Sepax isolated more endothelial progenitor cells in comparison 
to other intraoperative isolation procedures (Guven et al. 2012, Doi et al. 2013, 
SundarRaj et al. 2015). Nonetheless, more endothelial progenitor cells were not 
corresponding to less stromal cells or pericytes. In all differently obtained SVF, the 
origin of large numbers of cells remains unidentified. This is partly because not every 
study identified both adipose tissue-derived and blood-derived cell types, but 
probably not every subpopulation of all cell types is already known as well.  
When donor variability is neutralized by the use of the same lipoaspirate, 
intraoperative isolation procedures resulted in different SVF compositions. Lipogems 
isolated significantly more pericytes and stromal cells than the non-intraoperative 
isolation protocol control (p<0.05) (Bianchi et al. 2013) (Fig. 2). The enzymatic 
Celution system resulted in significantly more endothelial progenitor cells in 
comparison with the CHA-system, Lipokit system and Multi station, which is not 
necessarily preferred (p=0.003) (Aronowitz and Ellenhorn 2013). All other 
intraoperative isolation procedures compared with non-intraoperative isolation 
protocols showed no significant differences. 
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3.7. Modified IFATS/ISCT Index Score for the measurement of adipose tissue-
derived stromal vascular fraction 
Modified IFATS/ISCT index scores ranged from 1 to 4.6 out of 5. Güven et al. scored 
4.6 and presented the most complete characterization of the SVF and ASCs (Guven 
et al. 2012) (Table 5). Tonnard et al. scored 2 points, but had only used CD34 as a 
marker to identify a subpopulation in the SVF (Tonnard et al. 2013). Two studies 
used other methods than flow cytometry to determine the composition of SVF 
(Osinga et al. 2015, van Dongen et al. 2016). No studies were excluded based on a 
low number of outcomes of interest measured by the modified IFATS/ISCT Index 
Score, because five out of thirteen studies scored less than half of the possible 
points given. This high number of low scores given to studies underlines the need for 
standardization.  
3.8 Disclosure agreements of included articles 
A disclosure agreement of support by the manufacturer was provided in five of the 
thirteen studies (Lin et al. 2008, Guven et al. 2012, Aronowitz and Ellenhorn 2013, 
Bianchi et al. 2013, Doi et al. 2013) (Table 6, supplemental content). The company, 
which was mostly involved in the studies, was Cytori, the manufacturer of the 
enzymatic Celution system.  
 
4. Discussion  
Grafting of lipoaspirates and of SVF in particular, is a rapidly evolving treatment 
modality for scars and other skin defects, arthritis, neuropathy, diabetic ulcers to 
mention a few. Many of these, initially small scale, single center studies, are on the 
verge of expansion to multicenter placebo-controlled double-blind randomized 
clinical trials. An important prerequisite is the use of an efficient and standardized 
intraoperative isolation procedure of SVF. This systematic review shows that none of 
these procedures supersedes other procedures in terms of cell yield, viability and 
SVF composition while being time and cost efficient too when analyzed using the 
same lipoaspirate. However, three intraoperative isolation procedures (shuffling 5 
times, shuffling 30 times and Lipogems) showed only a minimal reduction of the 
volume of lipoaspirate, implicating that most of the adipocytes still are intact. 
Consequently, these three procedures are methods of processing rather than 
isolation procedures (Bianchi et al. 2013, Osinga et al. 2015). Moreover, there is a 
wide variation in cell yield, viability of cells and composition of SVF when all 
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intraoperative isolation procedures are compared together. Study characteristics 
showed small and varied sample sizes regarding the number, sex and age of the 
donors. It is known that the cell yield and viability of SVF differ among donors, 
depending on age, harvest location and co-morbidities, such as obesity, of the 
donors (Engels et al. 2013, Dos-Anjos Vilaboa et al. 2014, Di Taranto et al. 2015, 
Maredziak et al. 2016, Pachon-Pena et al. 2016). This interdonor variability is a 
possible explanation for the variations found between several studies. To avoid 
variation bias, isolation procedures should be investigated using identical 
lipoaspirates in the same study. There are, however, differences between non-
enzymatic and enzymatic isolated SVFs on a different level. Non-enzymatic isolation 
procedures resulted in larger volumes (tSVF) than the resulting pellets (cSVF) after 
enzymatic intraoperative isolation procedures. Because the final products of both 
types of isolation procedures are different, the clinical purpose of the use of SVF is 
an important factor which isolation procedure suits best. In some cases, such as the 
intra-articular injection of SVF in temporomandibular joints requires very small 
volumes, whereas the end volume of SVF enriched lipofilling is less relevant. 
Isolation procedures of SVF of adipose tissue are based on reduction of large 
volume containing tissue or cells, such as ECM and/or adipocytes to concentrate the 
stromal vascular fraction. Non-enzymatic isolation of SVF results in a smaller volume 
of adipose tissue containing intact ECM and cell-cell communications between SVF 
cells (tSVF), because the shear forces are too low to disrupt cell to cell and cell to 
ECM adhesions (Lin et al. 2008, Corselli et al. 2012). Therefore, the tissue structure 
of lipoaspirate is still intact in the tSVF. Enzymatic procedures, however, likely result 
in a single cell cSVF, because enzymes likely disrupt all cell-cell interactions and 
ECM (Fig. 3) (Aronowitz et al. 2015). This is may not happen in the Automated 
isolation system, GID SVF2, Lipokit system and Multi station, possibly due to 
insufficient enzymatic digestion (SundarRaj et al. 2015, Aronowitz et al. 2016). 
Clinical use of tSVF has several advantages over the use of cSVF in different 
clinical applications of regenerative medicine. It is well known that single cells 
migrate within 24 hours after application (Parvizi and Harmsen 2015). The ECM, 
containing a microvasculature structure, might function as a natural scaffold for cells 
like ASCs and most likely also augments rapid vascularization and reperfusion. This 
will probably increase cell retention rates after injection and enhance clinical effects. 
In case of early scar formation, wound healing, or organ fibrosis, tSVF might 
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therefore be more an appropriate therapy, which implicates that non-enzymatic 
procedures are more suitable as compared to enzymatic isolation procedures. In 
case of excessive pre-existing scar formation, the ECM in the SVF might not be 
appropriate and therefore the application of a cSVF or ASCs might be more eligible. 
ASCs could remodel excessive scar formation by immunomodulation or instruction of 
resident cells.  
Characterization of subpopulations in the SVF depends upon selection of 
appropriate markers. Selection of an insufficient number of markers will give a 
disfigured image of the actual SVF composition (Fig. 3). SVF of adipose tissue can 
be divided into two major subpopulations based on the expression of CD45, which is 
a hematopoietic cell marker: adipose derived (CD45min) and blood derived 
(CD45pos) (Yoshimura et al. 2006). Adipose derived cell populations can be divided 
into endothelial cells (CD31pos) and stromal cells (CD31min) (Yoshimura et al. 
2006). Three important subpopulations of the stromal cell population 
(CD45min/CD31min) are supra-adventitial cells: CD34pos/CD146min, pericytes: 
CD34pos/min/CD146pos and ASCs: CD34pos/CD90pos/CD105low (Yoshimura et 
al. 2006, Zimmerlin et al. 2010, Corselli et al. 2012, Corselli et al. 2013). Supra-
adventitial cells and pericytes are both identified as precursor cells of ASCs, 
although there remains some controversy about this item (Lin et al. 2008, Traktuev 
et al. 2008, Zimmerlin et al. 2010, Corselli et al. 2012). Ideally, to discriminate 
between those three cell types within the CD45min/CD31min subpopulation, CD146 
and/or CD90 markers should be used additionally. However, in most studies two CD 
markers or inappropriate combinations of CD markers have been used to determine 
cell types; only Lin et al. used all the aforementioned combinations (Lin et al. 2008). 
Because Lin et al. focus mainly on blood derived cells and not on the stromal cell 
population or pericytes, this did not affect their results. Doi et al. ascribed 
CD31min/CD34min/CD45min to the pericyte population, so therefore the CD34pos 
pericytes will be missed (Doi et al. 2013). SundarRaj et al. and Güven et al. used 
CD34pos/CD31min to determine the number of ASCs (Guven et al. 2012, SundarRaj 
et al. 2015), while pericytes and supra-adventitial cells also express CD34. 
Therefore, the number of ASCs contains pericytes and supra-adventitial cells as well 
(Yoshimura et al. 2006, Zimmerlin et al. 2010). To cover pericytes, supra-adventitial 
cells and ASCs, Domenis et al., Aronowitz et al. and Mashiko et al. used 
CD34pos/CD31min/CD45min to determine the stromal cell population (Aronowitz 
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and Ellenhorn 2013, Domenis et al. 2015, Aronowitz et al. 2016, Mashiko et al. 
2016). CD34pos is frequently used as a marker to describe cells with stem cell 
characteristics in both hematopoietic and non-hematopoietic stem cells (Suga et al. 
2009). The differences in use of CD marker expression to determine pericytes and 
the stromal cell population might be a possible explanation for the large variations 
found in SVF between different studies. No solid conclusions could be made about 
which isolation procedure generates the most stromal cells or pericytes. 
  Unfortunately, a limited number of commercially available intraoperative SVF 
isolation procedures not yet have reached scientific validation at an acceptable level. 
The American Society for Aesthetic Plastic Surgery (ASAPS) and the American 
Society of Plastic Surgeons (ASPS) published a position statement in 2012 on fat 
grafting and stem cells (Eaves et al. 2012). All specialized equipment for the use of 
stem cell extraction should be fully verified regarding efficacy and safety before use 
in clinical settings. In 2013, the IFATS and ICTS proposed guidelines with 
standardized endpoints and methods to verify and compare SVF isolation 
procedures (Bourin et al. 2013). None of the included studies fully verified their 
isolation procedure according to these IFATS and ICTS guidelines. Moreover, 
viability was measured in different ways among studies (e.g. directly on obtained 
SVF or after an extra non-intraoperative isolation protocol) and lipoaspirate was 
processed differently prior to isolation (e.g. centrifugation or decantation). For those 
reasons, we propose new adjusted IFATS and ICTS guidelines to validate 
intraoperative isolation procedures (Fig. 3). All intraoperative isolation procedures 
should be validated using centrifuged adipose tissue to determine the actual volume 
of lipoaspirate prior to isolation. It is known that increased centrifugal forces have a 
harmful effect on the viability of fat grafts (Xie et al. 2010, Tuin et al. 2016). However, 
the use of centrifuged adipose tissue is necessary to determine the actual cell yield 
after an isolation procedure. Furthermore, cell viability of tSVF should be determined 
directly on tSVF, instead of using an extra non-intraoperative isolation protocol which 
possibly results in more cell damage. However, the proposed adjusted standardized 
endpoints and methods by IFATS and ICTS are time-consuming and expensive 
since it requires cultured ASCs. In order to quickly verify isolation procedures 
intraoperatively during clinical trials, the end product of non-enzymatic intraoperative 
isolation procedures should be centrifuged to separate the oily fraction from the tSVF 
and pellet fraction based on density. For enzymatic intraoperative isolation 
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procedures, microscopy can be used to visualize single cells. In this way, isolation 
procedures can be quickly evaluated during clinical trials. 
A large number of SVF isolation procedures without applying a full verification 
according to the IFATS and ICTS guidelines is available (Oberbauer et al. 2015). 
Oberbauer et al. presented a narrative overview of enzymatic and non-enzymatic 
intraoperative SVF isolation procedures (Oberbauer et al. 2015). In twenty-one out of 
thirty (both enzymatic as well as non-enzymatic) intraoperative isolation procedures 
reported in their study, there was a lack of verification data. In two studies 
intraoperative isolation procedures without scientific evidence e.g. viability of SVF, 
flow cytometry of SVF cells and ASCs, were used to treat patients. One study used 
SVF obtained by ultrasonic cavitation to treat patients with migraine and tension 
headache (Bright et al. 2014). Another study used SVF in combination with platelet 
rich plasma for meniscus repair (Pak et al. 2014). Hence, it cannot be guaranteed 
that the isolation procedures indeed isolate SVF, which is clinical safe for use. It 
seems that the use of most SVF isolation procedures with its concomitant clinical 
application is far ahead of a sound scientific base upon which these procedures 
should be used.  
Moreover, the clinical safety of isolated SVF or ASCs is not clear yet, 
especially regarding clinical use in patients with any kind of malignancy. It is 
demonstrated, in vitro, that ASCs influence growth, progression and metastasis of 
cancer cell lines through e.g. promoting angiogenesis and differentiation of ASCs 
into carcinoma-associated fibroblasts (Freese et al. 2015). Zimmerlin et al. showed 
in vitro that ASCs influence growth of active malign cell lines, but this is not seen in 
latent cancer cell lines (Zimmerlin et al. 2011). Clinical data suggest that the use of 
isolated SVF or ASCs is safe in patients without an oncological history (Charvet et al. 
2015). In vitro studies often use higher concentrations of ASCs as compared to 
clinical studies and this might be the cause of differences found between in vitro and 
in vivo studies (Charvet et al. 2015). However, to test clinical safety it is important to 
reach scientific validation of the commercially available procedures at an acceptable 
level. In this review it become clear that the reproducibility of the procedures as well 
as characterization of the SVF had shortcomings. If this is reached, further scientific 
research with proper controls with regard to the clinical effect and safety of SVF or 
ASCs are definitely wanted. 
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5. Conclusion  
 
There is no evidence thus far that any intraoperative isolation procedure could be 
designated as preferred procedure for isolating SVF. However, three isolation 
procedures are rather processing techniques than isolation procedures. Enzymatic 
and non-enzymatic procedures had comparable results as it comes to cell yield, 
viability, and SVF composition. Non-enzymatic isolation procedures end products 
resulted had greater volumes (tSVF) than the pellets (cSVF) of the enzymatic 
isolation procedures. The results of intraoperative isolation procedures are 
comparable with those of the gold standard, the collagenase based non-
intraoperative isolation protocol. Since intraoperative isolation procedures are less 
time-consuming, but as efficient as the non-intraoperative isolation protocol, the use 
of intraoperative isolation procedures seems to be more suitable for clinical 
purposes. However, only small sample sizes have been used to validate the isolation 
procedures. To test clinical safety, it is important to reach scientific validation of the 
commercially available procedures at an acceptable level. Regarding to this review, 
this level is not yet reached by many procedures.  
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Figure 1. Flow diagram of study selection 
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Figure 2. SVF composition (CD marker) of procedures comparing an intraoperative 
isolation procedure with a non-intraoperative isolation protocol or with other 
intraoperative isolation procedures within one study. Stromal cell population 
(CD31min/CD34pos) consists of supra-adventitial cells, ASCs and pericytes, only 
pericytes defined as CD31min/CD146pos, CD31min/CD34min/pos or 
CD34min/CD146pos/CD90pos are placed separately in the table. Endothelial cells 
and vascular/progenitor endothelial cells are described as respectively, 
CD31pos/CD34min and CD31pos/CD34pos. No exact data described in text by 
Aronowitz et al., Bianchi et al., Domenis et al., Güven et al. and Mashiko et al., data 
is extracted from figures by authors JAD and AJT. AIS Automated Isolation System; 
CHA-station (CHA-Biotech); CYT Celution System Enzymatic (Cytori); FAST Fastem 
Corios (Corios); GID SVF2 (GID Europe); LIPOK Lipokit System (Medi-khan); PNC 
Multi station (PNC); REF Residual tissue of emulsified fat; SEPAX Sepax (Biosafe); 
SF Squeezed fat;Tissue Genesis Cell Isolation System (Tissue Genesis)  
 
  
 This article is protected by copyright. All rights reserved. 
 
Figure 3. A) Schematic overview of enzymatic versus non-enzymatic intraoperative 
isolation and characterization of the obtained cSVF or tSVF. B) Legend of figure 3A.  
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Table 1. Inclusion and exclusion criteria 
Inclusion criteria Exclusion criteria 
Clinical trials  Case reports 
Comparative studies Case series 
Full text available  Reviews 
All languages  Letters to editor 
Human studies Non-comparative studies 
 No full text available 
≥2 different types of SVF 
isolation procedures  
Processing methods for fat grafting 
Protocols using centrifugation or RBC lysis buffer only 
1 SVF isolation procedure 
compared with control 
group 
Intraoperative procedures  
Mesenchymal cells derived from other source than adipose tissue 
Blood saline fraction used instead of adipose fraction of the 
lipoaspirate 
Laboratory based enzyme protocols as experimental group  
No outcome of interest: SVF composition (CD markers), cell yield, 
viability of SVF 
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Table 2. Specific search terms of databases 
Search term Pubmed: 
 
((((Adipose Tissue [Mesh] OR Adipocytes [Mesh] OR Fat [tiab] OR Lipoaspirate* [tiab])) AND 
(Cell separation [Mesh] OR Isolat* [tiab] OR Dissociat* [tiab] OR Emulsification [tiab] OR 
Concentrat* [tiab] OR Digest* [tiab] OR Obtained [tiab])) AND (Stem cells [Mesh] OR Stromal 
cells [Mesh] OR Autologous progenitor cell* [tiab] OR Stromal vascular* [tiab] OR 
Regenerative cell* [tiab] OR Vascular stroma [tiab])) 
 
Restriction: Only human 
Search term Embase: 
 
('adipose tissue':ab,ti OR 'adipocytes':ab,ti OR 'fat':ab,ti OR lipoaspirate*:ab,ti AND ('cell 
separation' OR isolat*:ab,ti OR dissociat*:ab,ti OR 'emulsification':ab,ti OR concentrat*:ab,ti 
OR digest*:ab,ti OR 'obtained':ab,ti) AND ('stem cells':ab,ti OR 'stromal cells':ab,ti OR 
'autologous progenitor cell':ab,ti OR 'autologous progenitor cells':ab,ti OR 'stromal 
vascular':ab,ti OR 'stromal vascular fraction':ab,ti OR 'regenerative cell':ab,ti OR 'regenerative 
cells':ab,ti OR 'vascular stroma':ab,ti)) AND [embase]/lim NOT [medline]/lim AND 'article'/it  
 
Restriction: Only EMBASE 
 
Search term Cochrane Library: 
 
(adipose tissue OR adipocytes OR fat OR lipoaspirate*) AND (cell separation OR Isolat* OR 
Dissociat* OR Emulsification OR Concentrat* OR Digest* OR Obtained) AND (stem cells OR 
stromal cells OR autologous progenitor cell* OR stromal vascular* OR regenerative cell* OR 
vascular stroma) 
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Table 3A.  Duration, costs and procedure characteristics of intraoperative isolation procedures focusing on cSVF 
 
 

































SundarRaj et al. 
2015 
E A C 
Tissue digestion, heating and agitation, three-
stage filter system (100 micron, 35 micron, 5 
micron porosity) 





Aronowitz et al. 
2013 
E S C 
Fat bag, adapter, centrifugation, shaking 





D710 80-180 180 - - 
CYT 
Aronowitz et al. 
2013 
E A C 
Washing (lactated Ringer), tissue digestion 





D1950 100-180 360 - - 










360 5 [5] 30 
Domenis et al. 
2015   
60 D 250 - Pellet - 
Lin et al. 2008 90 - - - Pellet - 
GID-
SVF2 
Aronowitz et al. 
2016 
E M C 
Disposable canister for harvesting, filtration, 














Domenis et al. 
2015 
E S C 
1200 xg centrifugation (with a weight-mesh 




- - - - - - 





D530 60-100 100 - - 
















Aronowitz et al. 
2013 
E M O 
Centrifugation, shaking incubator, clean 




D460 100-150 400 - - 















Güven et al. 
2012 
E A C 







- 40-400 - Pellet - 
TGCIS Doi et al. 2012 E A C 




65 D 20-60 - Pellet - 
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AIS Automated Isolation System; CHA-station (CHA-Biotech); CYT Celution System Enzymatic (Cytori); GID SVF2 (GID Europe); 
LIPOK Lipokit System (Medi-khan); PNC Multi station (PNC); SEPAX Sepax (Biosafe); TGCIS Tissue Genesis Cell Isolation 
System (Tissue Genesis) 
 
 
Table 3B.  Duration, costs and procedure characteristics of intraoperative concentration procedures focusing on tSVF 
 
 

































Van Dongen et 
al. 2016 
N M O 
3000 rpm (radius 9.5 cm) centrifugation, 
shuffling through a 1.4 mm hole connector, 
3000 rpm (radius 9.5 cm) centrifugation 






Domenis et al. 
2015 
N M - 
Filterbag (120 micron filter), 400 xg 
centrifugation 
n/a - - - - 10 - 
FEF 
Mashiko et al.  
2016 
N M O 
1200 xg centrifugation, shuffling through a 
connector with three small holes 30 times, 
1200 xg centrifugation, fluid of decanting 
filtration (500-m pore size) used  
n/a - - - - - 9.9+/-2.0 
LIPOG 
Bianchi et al. 
2013  
N M C 
Filtering, decantation, stainless steel marbles 
to mix layers (oil, adipose tissue, blood, 
saline), washing, decantation, reversing 
devices, filtering 
n/a 20 D 40-130 130 60-100 1.3 
NANO 
Tonnard et al. 
2013 
N M O 
Shufling adipose tissue through a female-to-
female luerlok 30 times, filtering 
n/a - - - - - - 
REF 
Mashiko et al. 
2016 
N M O 
1200 xg centrifugation, shuffling through a 
connector with three small holes 30 times, 
1200 xg centrifugation, residual tissue of 
decanting filtration (500-m pore size) used 
n/a - - - - - 2.5+/-0.2 
SF 
Mashiko et al. 
2016 
N M O 
1200 xg centrifugation, squeeze using 
automated slicer, 1200 xg centrifugation  
n/a - - - - - 2.1+/-0.2 
SHUF5 
Osinga et al. 
2015 
N M O 
Shuffling lipoaspirate through female-to-




- 10 - - - 
SHUF30 
Osinga et al. 
2015 
N M O 
Shuffling lipoaspirate through female-to-




- 10 - - - 
STCELL Milan et al.  N M C 1000 xg centrifugation n/a - - 400 500 Pellet - 
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FAT Fractionation of Adipose Tissue procedure; FAST Fastem Corios (Corios); FEF Filtrated fluid of emulsified fat; LIPOG 
Lipogems (Lipogems); NANO Nanofat procedure; REF Residual tissue of emulsified fat; SF Squeezed fat; SHUF5 Shuffling 5 
times; SHUF30 Shuffling 30 times  
 
 This article is protected by copyright. All rights reserved. 
Table 4A: Effect sizes of studies evaluating enzymatic intraoperative isolation 
procedures regarding cell yield  





Study N Cell yield 
x10^5 cells 




AIS, SundarRaj, 2015 11 1.17 0.5 11 1.15 0.30 0,07 
CYT, Domenis, 2015  9 11.7 5.0 16 6.7 3.30 1,52 
CYT, Lin, 2008 6 3.7 0.9 3 4.96 0.72 -1,75 
LIPOK, Domenis, 2015 9 5.0 3.0 16 6.7 3.30 -0,52 
SEPAX, Güven, 2012 6 2.6 1.2 6 1.6 0.90 1,11 
TGCIS, Doi, 2012 6 7.0 1.9 6 7.0 2.43 0,00 
 
AIS Automated Isolation System; CYT Celution System Enzymatic (Cytori); LIPOK 
Lipokit System (Medi-khan); SEPAX Sepax (Biosafe); TGCIS Tissue Genesis Cell 
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Table 4B. Effect sizes of studies evaluating viable nucleated cells 
 
 
a No exact data described in text, data extracted from figures by authors JAD and 
AJT. AIS Automated Isolation System; CYT Celution System Enzymatic (Cytori); 
FEF Filtrated fluid of emulsified fat; REF Residual tissue of emulsified fat; SF 






   Procedure  Non-intraoperative 
isolation protocol 
 
Study N % viable 
cells 




Enzymatic        
AIS, SundarRaj, 2015 11 97.5 2.8 11 97.3 1.5 0.13 
CYT, Lin, 2008 3 89.2 1.1 3 90.8 1.3 -1.23 
TGCIS, Doi, 2012 6 80.7 7.1 6 82.4 7.7 -0.22 
Non-enzymatic        
FEF, Mashiko, 2016 10 39.3 9.1 10 93.8 1.2 -45.4 
REF, Mashiko, 2016 10 90.6 2.8 10 93.8 1.2 -2.67 
SF, Mashiko, 2016 10 89.9 4.6 10 93.8 1.2 -3.25 
STCELL, Millan, 2014
 a
 3 87.7 8.9 3 74.5 20.1 0.66 
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Table 5. Modified IFATS index score for the measurement of adipose tissue-derived 
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1 1          1    3.00 
Bianchi et al. 
2013 
1 1 
         
0  1/3  1/3  1/3 3.00 
Doi et al. 2012 1 1 
         
0 
   
2.00 


















   
2.78 
Van Dongen 
et al. 2016 
1 0  1/9 1/9 1/9 1/9  1/9 1/9  1 1/3 1/3  3.33 














1  1/3  1/3  1/3 4.56 
Lin et al. 2008 1 1 
         
1  1/3  1/3 
 
3.67 
Mashiko et al. 
2016 
1 1          0    2.00 
Millan et al.  1 0 










   
1.44 
Osinga et al. 
2015 
1 0 
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3.00 
Tonnard et al. 
2013 
0 1 
         
0  1/3 
  
1.33 
 
